MLL-AF4PAF1FACT,

Nicholas T Crump1,2, Alastair L Smith3, Laura Godfrey3

  • 1MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DS, UK. n.crump@imperial.ac.uk.

Nature communications
|August 25, 2023
PubMed
概括

异常的增强器激活驱动癌症. 这项研究表明,MLL-AF4融合蛋白在白血病中产生广泛的增强剂-促进剂相互作用,这取决于像PAF1C和FACT这样的转录延长因子.